Suppr超能文献

稳心颗粒对钠通道电流的心房选择性抑制作用可有效抑制心房颤动。

Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation.

机构信息

Masonic Medical Research Laboratory, Utica, New York 13501, USA.

出版信息

Heart Rhythm. 2012 Jan;9(1):125-31. doi: 10.1016/j.hrthm.2011.08.027. Epub 2011 Aug 30.

Abstract

BACKGROUND

Wenxin Keli is a Chinese herb extract reported to be of benefit in the treatment of cardiac arrhythmias, cardiac inflammation, and heart failure.

METHODS AND RESULTS

We evaluated the electrophysiologic effects of Wenxin Keli in isolated canine arterially perfused right atrial preparations with a rim of right ventricular tissue (n = 11). Transmembrane action potentials and a pseudoelectrocardiogram were simultaneously recorded. Acetylcholine (1 μM) was used to induce atrial fibrillation (AF) and to test the anti-AF potential of Wenxin Keli (5 g/L). Wenxin Keli produced preferential abbreviation of action potential duration measured at 90% repolarization (APD(90)) in atria, but caused atrial-selective prolongation of the effective refractory period, due to the development of postrepolarization refractoriness. The maximum rate of rise of the action potential upstroke was preferentially reduced in atria. The diastolic threshold of excitation increased in both atria and ventricles, but much more in atria. The duration of the "P wave" (index of atrial conduction time) was prolonged to a much greater extent than the duration of the "QRS complex" (index of ventricular conduction time). Wenxin Keli significantly reduced I(Na) and shifted steady-state inactivation to more negative potentials in HEK293 cells stably expressing SCN5A. Wenxin Keli prevented the induction of persistent AF in 100% atria (6/6) and, in another experimental series, was found to terminate persistent acetylcholine-mediated AF in 100% of atria (3/3).

CONCLUSION

Wenxin Keli produces atrial-selective depression of I(Na)-dependent parameters in canine isolated coronary-perfused preparations via a unique mechanism and is effective in suppressing AF and preventing its induction, with minimal effects on the ventricular electrophysiology.

摘要

背景

稳心颗粒是一种中药提取物,据报道可用于治疗心律失常、心脏炎症和心力衰竭。

方法和结果

我们评估了稳心颗粒在离体犬冠状血管灌注右心房标本(带右心室边缘组织)中的电生理效应(n=11)。同时记录跨膜动作电位和伪心电图。使用乙酰胆碱(1μM)诱导心房颤动(AF),并测试稳心颗粒(5g/L)的抗 AF 潜力。稳心颗粒使心房复极 90%(APD90)时的动作电位时程优先缩短,但由于后除极不应期的发展,导致心房选择性有效不应期延长。动作电位上升最大速度在心房中优先降低。心房和心室的舒张阈值兴奋性均增加,但心房增加更多。“P 波”(心房传导时间指标)的持续时间比“QRS 复合波”(心室传导时间指标)延长得更多。稳心颗粒在稳定表达 SCN5A 的 HEK293 细胞中显著降低 I(Na)并将稳态失活向更负的电位转移。稳心颗粒可防止 100%的心房(6/6)持续诱导 AF,并在另一个实验系列中发现可终止 100%的乙酰胆碱介导的持续性 AF(3/3)。

结论

稳心颗粒通过独特的机制在犬离体冠状血管灌注标本中产生心房选择性的 I(Na)依赖性参数抑制,并有效抑制 AF 的发生,对心室电生理的影响最小。

相似文献

引用本文的文献

4
Advances in basic and translational research in atrial fibrillation.心房颤动的基础和转化研究进展。
Philos Trans R Soc Lond B Biol Sci. 2023 Jun 19;378(1879):20220174. doi: 10.1098/rstb.2022.0174. Epub 2023 May 1.

本文引用的文献

7
New developments in atrial antiarrhythmic drug therapy.心房抗心律失常药物治疗的新进展。
Nat Rev Cardiol. 2010 Mar;7(3):139-48. doi: 10.1038/nrcardio.2009.245.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验